Lyophilized Injectable Market

Lyophilized Injectable Market (Type of Packaging: Single-use Vials, Point-of-care Reconstitution, and Specialty Packaging; Type of Delivery: Prefilled Diluent Syringes, Proprietary Reconstitution Devices, Single-step Devices, and Multi-step Devices; Indication: Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, and Others; and End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

EUA of Remdesivir Lyophilized Powder for COVID-19 Treatment in India

The ever-evolving nature of coronavirus has become a major threat to the public health, owing to its severe respiratory symptoms. Ongoing studies are surfacing about the safety and efficacy of novel lyophilized therapeutic agents in hospitalized adult patients diagnosed with COVID-19. Amid all this, healthcare giant Cipla - a global pharmaceutical company is gaining recognition for introducing its CIPREMI, a remdesivir lyophilized powder for injection (100mg). Manufacturers in the lyophilized injectable market are taking cues from such innovations to increase the availability of the U.S. FDA-approved emergency use authorization (EUA) treatment for patients with severe COVID-19 symptoms.

Since India is suffering from a third wave of the pandemic, companies in the India lyophilized injectable market are increasing efforts to gain regulatory approval by the Drug Controller General of India (DCGI) for restricted emergency use in the country.

lyophilized injectable market infographic

To know the scope of our report Get a Sample on Lyophilized Injectable Market

Alternative Vial Designs Help Reduce Lyo-breakage Risk, Side-load Force

The lyophilized injectable market is expected to surpass US$ 5 Bn by 2031. Packaging plays a crucial role in the lyophilization of injectable drugs. Though lyo-breakage is generally not a routine occurrence, however, even at a low frequency, it can lead to high cost and operational impacts. Hence, companies are adopting alternative vial designs to reduce lyo-breakage risk and reduce significant side-load force during vial transfer in/out of the lyophilizer.

Since lyophilization is a demanding process performed with costly equipment, manufacturers are reducing significant vertical-load forces during stopper closure to avoid lyo-breakage.

Get a glimpse of the in-depth analysis through our Report Brochure

Freeze-drying Preserve Liquid Formulations for Longer Periods

The lyophilized injectable market is estimated to clock a CAGR of ~5% during the forecast period. However, many biotechnologically manufactured substances are not sufficiently stable in aqueous solutions. This becomes challenging to preserve liquid formulations for longer periods. In order to overcome this, companies are adopting freeze-drying by which water is extracted from the substance under vacuum and low temperatures. There is a growing awareness to reconstitute drugs before administering them to patients.

Companies in the lyophilized injectable market are bolstering their production capabilities in freeze-dried substances, which are being packaged in vials, dual-chamber syringes, and dual-chamber cartridges. Vials have set the gold standard for freeze-dried products.

Embedded Electronic Features to Transform Market Landscape

Universal, customizable, and upgradable drug devices are anticipated to help companies in the lyophilized injectable market gain a competitive edge over other market players during the forecast period. Manufacturers are boosting their R&D to develop devices and injectors that are universal in nature and capable of operating with the help of any primary container, sans the need for a drug transfer step.

Embedded electronic features in devices and injectors are predicted to emerge as a game changer for stakeholders in the global lyophilized injectable market. These features will allow customization depending on the intended user type. Other connectivity capabilities will enable devices to be remotely upgraded, whilst making the task of lifecycle management easier.

Improving Durability of Molded Vials Yields Better Performance in Lyophilization Applications

As companies in the lyophilized injectable market are gaining awareness about the exact causes of lyo-breakage, they are increasing their production capabilities in stronger vials that may lead to a reduced likelihood of occurrence. SGD Pharma - a specialist in the production of pharmaceutical glass primary packaging has introduced its EasyLyo vial range, which combines the strength and chemical durability of molded vials with characteristics of thin-walled vials.

Manufacturers in the lyophilized injectable market are increasing efforts to reduce breakage rates and heat-transfer capability in vials. They are conducting several lyo-breakage tests using worst-case injectable formulations and cycle designed to break vials. Companies are producing flat base vials with squared-off shoulder and heel vials to yield better performance in lyophilization applications.

lyophilized injectable market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report

Analysts’ Viewpoint

Companies in the lyophilized injectable market are anticipated to enter into partnerships to increase accessibility to remdesivir for patients suffering from COVID-19 in India. Injectable devices are expected to align with the increased requirement of greener technologies. However, lyo-breakage is emerging as a major issue in packaging applications. Hence, companies should develop vials with improved uniformity and cosmetic nature to offer better inspectability & performance as compared to standard molded vials. They are developing injectors that will allow patients to take control of their disease by monitoring their drug performance. Dual-chamber syringes are one of the most innovative packaging forms for freeze-dried products.

Lyophilized Injectable Market: Overview

  • Lyophilization is the most commonly used method for the manufacturing of parenteral pharmaceutical products, when the product is unstable in aqueous solution. It is central to the protection of materials, which require low moisture content (less than 1%) in order to ensure stability and require a sterile and gentle preservation process.
  • Improved quality and shelf life of lyophilized drugs has attracted industry experts to implement lyophilization in their manufacturing processes. Contract research and manufacturing organizations have increased the use of lyophilized injectable drugs to provide quality products to customers. Therefore, rapidly growing contract research manufacturing services (CRAMS) is projected to drive the global lyophilized injectable market.
  • Lyophilized injectable drugs are stable at ambient temperatures and only require simple rehydration to be ready to use. This removes many sources of pipetting errors, while streamlining and simplifying workflows.
  • Elimination of the cold chain minimizes costs and carbon footprint, and provides a positive environmental impact by minimizing the need of expanded polystyrene (EPS or ‘Styrofoam’) containers often utilized to ship temperature-controlled products
  • Lyophilized products are considered safe for use, while delivering the desired functionality compared to non-lyophilized products. Moreover, lyophilization helps retain the biological and chemical activity of the chemical compound in the final product. This drives the demand for lyophilized injectable drugs in the pharmaceutical and biotechnology industries.

Market Segmentation: Lyophilized Injectable Market

  • In terms of type of packaging, the global lyophilized injectable market has been classified into single-use vials, point-of-care reconstitution, and specialty packaging
  • Based on type of delivery, the global lyophilized injectable market has been categorized into prefilled diluent syringes, proprietary reconstitution devices, single-step devices, and multi-step devices
  • In terms of indication, the global lyophilized injectable market has been segregated into autoimmune diseases, metabolic conditions, infectious diseases, and others
  • Based on end user, the global lyophilized injectable market has been divided into hospitals, specialty clinics, ambulatory surgical centers, and others
  • Each of the segments has been analyzed in detail for trends, recent trends & developments, drivers, restraints, opportunities, and useful insights. The lyophilized injectable market report provides current and future revenue (US$ Mn) for each of these segments for the period from 2017 to 2031, considering 2020 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2021 to 2031, along with market size estimations.

Regional Overview: Lyophilized Injectable Market

  • In terms of region, the global lyophilized injectable market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
  • The U.S. held a prominent share of the lyophilized injectable market in North America in 2019. The region is projected to dominate the global market during the forecast period, owing to increase in incidence rate of chronic diseases and higher rate of adoption of lyophilized injectable drugs in countries in the region.
  • The lyophilized injectable market in Asia Pacific is anticipated to expand at the fastest CAGR from 2018 to 2026. The region comprises emerging economies such as China, India, Indonesia, Malaysia, Singapore, and Thailand. Asia Pacific offers significant opportunities in the healthcare sector, and was the third-largest market in the world in 2017. These countries present large opportunities in the healthcare sector. The lyophilized injectable market in Asia Pacific is expected to grow at a rapid pace over the next few years due to untapped opportunities, improving healthcare infrastructure, and increasing availability of contract manufacturing & research services.
  • The study also offers a list of recommendations, highlights, and useful insights of the market, which are likely to help new companies willing to enter the lyophilized injectable market and existing companies to increase market share and in the decision-making process

Major Lyophilized Injectable Market Players

  • The report concludes with the company profiles section that includes key information about the major players in the global lyophilized injectable market
  • Leading players analyzed in the lyophilized injectable market report are
    • B. Braun Melsungen AG
    • Baxter International, Inc.
    • BD
    • Schott AG
    • Aristopharma Ltd.
    • Vetter Pharma
    • Jubilant HollisterStier LLC
    • among others
  • Each of these players has been profiled in the lyophilized injectable market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Lyophilized Injectable Market – Segmentation

TMR’s study on the global lyophilized injectable market includes information divided into five segments: type of packaging, type of delivery, indication, end user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global lyophilized injectable market have been discussed in detail.

Type of Packaging
  • Single-use Vials
  • Point-of-care Reconstitution
  • Specialty Packaging
Type of Delivery
  • Prefilled Diluent Syringes
  • Proprietary Reconstitution Devices
  • Single-step Devices
  • Multi-step Devices
Indication
  • Autoimmune Diseases
  • Infectious Diseases
  • Metabolic Conditions
  • Others
End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of lyophilized injectable market?

Lyophilized injectable market is expected to surpass US$ 5 Bn by 2031

What is the anticipated CAGR of the lyophilized injectable market in the forecast period?

Lyophilized injectable market is projected to expand at a CAGR of ~5% from 2021 to 2031

What are the key driving factors for the growth of the lyophilized injectable market?

Lyophilized injectable market is driven by rapidly growing contract research manufacturing services (CRAMS) and expansion of pipeline of lyophilized injectable drugs

What are the end-use segments in the lyophilized injectable market?

The end-use segments in lyophilized injectable market are hospitals, ambulatory surgical centers and specialty clinics

Who are the key players in the global lyophilized injectable market?

Key players in the global lyophilized injectable market include B. Braun Melsungen AG, Baxter International, Inc., BD, Schott AG, Aristopharma Ltd., Vetter Pharma, and Jubilant HollisterStier LLC.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Lyophilized Injectable Market 

    4. Market Overview

        4.1. Introduction & Overview

        4.2. Market Dynamics

            4.2.1. Drivers

            4.2.2. Restraints

            4.2.3. Opportunities 

        4.3. Global Lyophilized Injectable Market Analysis and Forecast, 2017–2031

    5. Market Outlook 

        5.1. COVID-19 Pandemics Impact on Industry

        5.2. Key Industry Developments

        5.3. Pipeline Analysis

        5.4. Top 10 Lyophilized Drug Products

        5.5. Regulatory Scenario

    6. Global Lyophilized Injectable Market Analysis and Forecast, by Type of Packaging

        6.1. Introduction & Definition

        6.2. Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031

            6.2.1. Single-use Vials

            6.2.2. Point-of-care Reconstitution

            6.2.3. Specialty Packaging

        6.3. Global Lyophilized Injectable Market Attractiveness Analysis, by Type of Packaging

    7. Global Lyophilized Injectable Market Analysis and Forecast, by Type of Delivery

        7.1. Introduction & Definition

        7.2. Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031

            7.2.1. Prefilled Diluent Syringes

            7.2.2. Proprietary Reconstitution Devices

            7.2.3. Single-step Devices

            7.2.4. Multi-step Devices

        7.3. Global Lyophilized Injectable Market Attractiveness Analysis, by Type of Delivery

    8. Global Lyophilized Injectable Market Analysis and Forecast, by Indication

        8.1. Introduction & Definition

        8.2. Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031

            8.2.1. Autoimmune Diseases

            8.2.2. Metabolic Conditions

            8.2.3. Infectious Diseases

            8.2.4. Others

        8.3. Global Lyophilized Injectable Market Attractiveness Analysis, by Indication

    9. Global Lyophilized Injectable Market Analysis and Forecast, by End-user

        9.1. Introduction & Definition

        9.2. Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031

            9.2.1. Hospitals

            9.2.2. Ambulatory Surgical Centers

            9.2.3. Specialty Clinics

            9.2.4. Others

        9.3. Global Lyophilized Injectable Market Attractiveness Analysis, by End-user

    10. Global Lyophilized Injectable Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Region

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Global Lyophilized Injectable Market Attractiveness Analysis, by Region

    11. North America Lyophilized Injectable Market Analysis and Forecast

        11.1. Introduction

        11.2. North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031

            11.2.1. Single-use Vials

            11.2.2. Point-of-care Reconstitution

            11.2.3. Specialty Packaging

        11.3. North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031

            11.3.1. Prefilled Diluent Syringes

            11.3.2. Proprietary Reconstitution Devices

            11.3.3. Single-step Devices

            11.3.4. Multi-step Devices

        11.4. North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031

            11.4.1. Autoimmune Diseases

            11.4.2. Metabolic Conditions

            11.4.3. Infectious Diseases

            11.4.4. Others 

        11.5. North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031

            11.5.1. Hospitals

            11.5.2. Ambulatory Surgical Centers

            11.5.3. Specialty Clinics

            11.5.4. Others

        11.6. North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country, 2017–2031

            11.6.1. U.S.

            11.6.2. Canada

        11.7. North America Lyophilized Injectable Market Attractiveness Analysis

            11.7.1. By Type of Packaging

            11.7.2. By Type of Delivery

            11.7.3. By Indication

            11.7.4. By End-user

            11.7.5. By Country 

    12. Europe Lyophilized Injectable Market Analysis and Forecast

        12.1. Introduction

        12.2. Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031

            12.2.1. Single-use Vials

            12.2.2. Point-of-care Reconstitution

            12.2.3. Specialty Packaging

        12.3. Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031

            12.3.1. Prefilled Diluent Syringes

            12.3.2. Proprietary Reconstitution Devices

            12.3.3. Single-step Devices

            12.3.4. Multi-step Devices

        12.4. Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031

            12.4.1. Autoimmune Diseases

            12.4.2. Metabolic Conditions

            12.4.3. Infectious Diseases

            12.4.4. Others 

        12.5. Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031

            12.5.1. Hospitals

            12.5.2. Ambulatory Surgical Centers

            12.5.3. Specialty Clinics

            12.5.4. Others

        12.6. Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

            12.6.1. Germany

            12.6.2. U.K.

            12.6.3. France

            12.6.4. Spain

            12.6.5. Italy

            12.6.6. Rest of Europe

        12.7. Europe Lyophilized Injectable Market Attractiveness Analysis

            12.7.1. By Type of Packaging

            12.7.2. By Type of Delivery

            12.7.3. By Indication

            12.7.4. By End-user

            12.7.5. By Country/Sub-region

    13. Asia Pacific Lyophilized Injectable Market Analysis and Forecast

        13.1. Introduction

        13.2. Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031

            13.2.1. Single-use Vials

            13.2.2. Point-of-care Reconstitution

            13.2.3. Specialty Packaging

        13.3. Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031

            13.3.1. Prefilled Diluent Syringes

            13.3.2. Proprietary Reconstitution Devices

            13.3.3. Single-step Devices

            13.3.4. Multi-step Devices

        13.4. Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031

            13.4.1. Autoimmune Diseases

            13.4.2. Metabolic Conditions

            13.4.3. Infectious Diseases

            13.4.4. Others 

        13.5. Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031

            13.5.1. Hospitals

            13.5.2. Ambulatory Surgical Centers

            13.5.3. Specialty Clinics

            13.5.4. Others

        13.6. Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

            13.6.1. China

            13.6.2. Japan

            13.6.3. India

            13.6.4. Australia & New Zealand

            13.6.5. Rest of Asia Pacific

        13.7. Asia Pacific Lyophilized Injectable Market Attractiveness Analysis

            13.7.1. By Type of Packaging

            13.7.2. By Type of Delivery

            13.7.3. By Indication

            13.7.4. By End-user 

            13.7.5. By Country/Sub-region

    14. Latin America Lyophilized Injectable Market Analysis and Forecast

        14.1. Introduction

        14.2. Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031

            14.2.1. Single-use Vials

            14.2.2. Point-of-care Reconstitution

            14.2.3. Specialty Packaging

        14.3. Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031

            14.3.1. Prefilled Diluent Syringes

            14.3.2. Proprietary Reconstitution Devices

            14.3.3. Single-step Devices

            14.3.4. Multi-step Devices

        14.4. Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031

            14.4.1. Autoimmune Diseases

            14.4.2. Metabolic Conditions

            14.4.3. Infectious Diseases

            14.4.4. Others 

        14.5. Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031

            14.5.1. Hospitals

            14.5.2. Ambulatory Surgical Centers

            14.5.3. Specialty Clinics

            14.5.4. Others

        14.6. Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

            14.6.1. Brazil

            14.6.2. Mexico

            14.6.3. Rest of Latin America

        14.7. Latin America Lyophilized Injectable Market Attractiveness Analysis

            14.7.1. By Type of Packaging

            14.7.2. By Type of Delivery

            14.7.3. By Indication

            14.7.4. By End-user 

            14.7.5. By Country/Sub-region

    15. Middle East & Africa Lyophilized Injectable Market Analysis and Forecast

        15.1. Introduction

        15.2. Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031

            15.2.1. Single-use Vials

            15.2.2. Point-of-care Reconstitution

            15.2.3. Specialty Packaging

        15.3. Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031

            15.3.1. Prefilled Diluent Syringes

            15.3.2. Proprietary Reconstitution Devices

            15.3.3. Single-step Devices

            15.3.4. Multi-step Devices

        15.4. Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031

            15.4.1. Autoimmune Diseases

            15.4.2. Metabolic Conditions

            15.4.3. Infectious Diseases

            15.4.4. Others 

        15.5. Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031

            15.5.1. Hospitals

            15.5.2. Ambulatory Surgical Centers

            15.5.3. Specialty Clinics

            15.5.4. Others

        15.6. Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

            15.6.1. GCC Countries

            15.6.2. South Africa

            15.6.3. Rest of Middle East & Africa

        15.7. Middle East & Africa Lyophilized Injectable Market Attractiveness Analysis

            15.7.1. By Type of Packaging

            15.7.2. By Type of Delivery

            15.7.3. By Indication

            15.7.4. By End-user 

            15.7.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Position Analysis, by Company, 2019

        16.2. Company Profiles

            16.2.1. B. Braun Melsungen AG

                16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.1.2. Growth Strategies

                16.2.1.3. SWOT Analysis

            16.2.2. Baxter International, Inc.

                16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.2.2. Growth Strategies

                16.2.2.3. SWOT Analysis

            16.2.3. BD

                16.2.3.1. Company Overview (HQ, Business Segments)

                16.2.3.2. Growth Strategies

                16.2.3.3. SWOT Analysis

            16.2.4. SCHOTT AG

                16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.4.2. Growth Strategies

                16.2.4.3. SWOT Analysis

            16.2.5. Aristopharma Ltd.

                16.2.5.1. Company Overview (HQ, Business Segments)

                16.2.5.2. Growth Strategies

                16.2.5.3. SWOT Analysis

            16.2.6. Vetter Pharma

                16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.6.2. Growth Strategies

                16.2.6.3. SWOT Analysis

            16.2.7. Jubilant HollisterStier LLC

                16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.7.2. Growth Strategies

                16.2.7.3. SWOT Analysis

    List of Tables

    Table 01: Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031

    Table 02: Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031

    Table 03: Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031

    Table 04: Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 05: Global Lyophilized Injectable Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 06: North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 07: North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031

    Table 08: North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031

    Table 09: North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031

    Table 10: North America Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 11: Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 12: Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031

    Table 13: Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031

    Table 14: Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031

    Table 15: Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 16: Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 17: Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031

    Table 18: Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031

    Table 19: Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031

    Table 20: Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031

    Table 23: Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031

    Table 24: Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031

    Table 25: Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 26: Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 27: Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Packaging, 2017–2031

    Table 28: Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by Type of Delivery, 2017–2031

    Table 29: Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by Indication, 2017–2031

    Table 30: Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Lyophilized Injectable Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 02: Global Lyophilized Injectable Market Value Share, by Region, 2020

    Figure 03: Global Lyophilized Injectable Market Value Share Analysis, by Type of Packaging, 2020 and 2031

    Figure 04: Global Lyophilized Injectable Market Attractiveness Analysis, by Type of Packaging, 2021–2031

    Figure 05: Global Lyophilized Injectable Market Value (US$ Mn), by Single-use Vials, 2017–2031

    Figure 06: Global Lyophilized Injectable Market Value (US$ Mn), by Point-of-care Reconstitution, 2017–2031

    Figure 07: Global Lyophilized Injectable Market Value (US$ Mn), by Specialty Packaging, 2017–2031

    Figure 08: Global Lyophilized Injectable Market Value Share Analysis, by Type of Delivery, 2020 and 2031

    Figure 09: Global Lyophilized Injectable Market Attractiveness Analysis, by Type of Delivery, 2021–2031

    Figure 10: Global Lyophilized Injectable Market Value (US$ Mn), by Prefilled Diluent Syringes, 2017–2031

    Figure 11: Global Lyophilized Injectable Market Value (US$ Mn), by Proprietary Reconstitution Devices, 2017–2031

    Figure 12: Global Lyophilized Injectable Market Value (US$ Mn), by Single-step devices, 2017–2031

    Figure 13: Global Lyophilized Injectable Market Value (US$ Mn), by Multi-step devices, 2017–2031

    Figure 14: Global Lyophilized Injectable Market Value Share Analysis, by Indication, 2020 and 2031

    Figure 15: Global Lyophilized Injectable Market Attractiveness Analysis, by Indication, 2021–2031

    Figure 16: Global Lyophilized Injectable Market Value (US$ Mn), by Autoimmune Diseases, 2017–2031

    Figure 17: Global Lyophilized Injectable Market Value (US$ Mn), by Infectious Diseases, 2017–2031

    Figure 18: Global Lyophilized Injectable Market Value (US$ Mn), by Metabolic Conditions, 2017–2031

    Figure 19: Global Lyophilized Injectable Market Value (US$ Mn), by Others, 2017–2031

    Figure 20: Global Lyophilized Injectable Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 21: Global Lyophilized Injectable Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 22: Global Lyophilized Injectable Market Value (US$ Mn), by Hospitals, 2017–2031

    Figure 23: Global Lyophilized Injectable Market Value (US$ Mn), by Ambulatory Surgical Centers, 2017–2031

    Figure 24: Global Lyophilized Injectable Market Value (US$ Mn), by Specialty Clinics, 2017–2031

    Figure 25: Global Lyophilized Injectable Market Value (US$ Mn), by Others, 2017–2031

    Figure 26: Global Lyophilized Injectable Market Value Share Analysis, by Region, 2020 and 2031

    Figure 27: Global Lyophilized Injectable Market Attractiveness Analysis, by Region, 2021–2031

    Figure 28: North America Lyophilized Injectable Market Value (US$ Mn) Forecast, 2017–2031

    Figure 29: North America Lyophilized Injectable Market Value Share Analysis, by Country, 2020 and 2031

    Figure 30: North America Lyophilized Injectable Market Attractiveness Analysis, by Country, 2021–2031

    Figure 31: North America Lyophilized Injectable Market Value Share Analysis, by Type of Packaging, 2020 and 2031

    Figure 32: North America Lyophilized Injectable Market Attractiveness Analysis, by Type of Packaging, 2021–2031

    Figure 33: North America Lyophilized Injectable Market Value Share Analysis, by Type of Delivery, 2020 and 2031

    Figure 34: North America Lyophilized Injectable Market Attractiveness Analysis, by Type of Delivery, 2021–2031

    Figure 35: North America Lyophilized Injectable Market Value Share Analysis, by Indication, 2020 and 2031

    Figure 36: North America Lyophilized Injectable Market Attractiveness Analysis, by Indication, 2021–2031

    Figure 37: North America Lyophilized Injectable Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 38: North America Lyophilized Injectable Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 39: Europe Lyophilized Injectable Market Value (US$ Mn) Forecast, 2017–2031

    Figure 40: Europe Lyophilized Injectable Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 41: Europe Lyophilized Injectable Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 42: Europe Lyophilized Injectable Market Value Share Analysis, by Type of Packaging, 2020 and 2031

    Figure 43: Europe Lyophilized Injectable Market Attractiveness Analysis, by Type of Packaging, 2021–2031

    Figure 44: Europe Lyophilized Injectable Market Value Share Analysis, by Type of Delivery, 2020 and 2031

    Figure 45: Europe Lyophilized Injectable Market Attractiveness Analysis, by Type of Delivery, 2021–2031

    Figure 46: Europe Lyophilized Injectable Market Value Share Analysis, by Indication, 2020 and 2031

    Figure 47: Europe Lyophilized Injectable Market Attractiveness Analysis, by Indication, 2021–2031

    Figure 48: Europe Lyophilized Injectable Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 49: Europe Lyophilized Injectable Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 50: Asia Pacific Lyophilized Injectable Market Value (US$ Mn) Forecast, 2017–2031

    Figure 51: Asia Pacific Lyophilized Injectable Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 52: Asia Pacific Lyophilized Injectable Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 53: Asia Pacific Lyophilized Injectable Market Value Share Analysis, by Type of Packaging, 2020 and 2031

    Figure 54: Asia Pacific Lyophilized Injectable Market Attractiveness Analysis, by Type of Packaging, 2021–2031

    Figure 55: Asia Pacific Lyophilized Injectable Market Value Share Analysis, by Type of Delivery, 2020 and 2031

    Figure 56: Asia Pacific Lyophilized Injectable Market Attractiveness Analysis, by Type of Delivery, 2021–2031

    Figure 57: Asia Pacific Lyophilized Injectable Market Value Share Analysis, by Indication, 2020 and 2031

    Figure 58: Asia Pacific Lyophilized Injectable Market Attractiveness Analysis, by Indication, 2021–2031

    Figure 59: Asia Pacific Lyophilized Injectable Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 60: Asia Pacific Lyophilized Injectable Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 61: Latin America Lyophilized Injectable Market Value (US$ Mn) Forecast, 2017–2031

    Figure 62: Latin America Lyophilized Injectable Market Value Share Analysis, by Country, 2020 and 2031

    Figure 63: Latin America Lyophilized Injectable Market Attractiveness Analysis, by Country, 2021–2031

    Figure 64: Latin America Lyophilized Injectable Market Value Share Analysis, by Type of Packaging, 2020 and 2031

    Figure 65: Latin America Lyophilized Injectable Market Attractiveness Analysis, by Type of Packaging, 2021–2031

    Figure 66: Latin America Lyophilized Injectable Market Value Share Analysis, by Type of Delivery, 2020 and 2031

    Figure 67: Latin America Lyophilized Injectable Market Attractiveness Analysis, by Type of Delivery, 2021–2031

    Figure 68: Latin America Lyophilized Injectable Market Value Share Analysis, by Indication, 2020 and 2031

    Figure 69: Latin America Lyophilized Injectable Market Attractiveness Analysis, by Indication, 2021–2031

    Figure 70: Latin America Lyophilized Injectable Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 71: Latin America Lyophilized Injectable Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 72: Middle East & Africa Lyophilized Injectable Market Value (US$ Mn) Forecast, 2017–2031

    Figure 73: Middle East & Africa Lyophilized Injectable Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 74: Middle East & Africa Lyophilized Injectable Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 75: Middle East & Africa Lyophilized Injectable Market Value Share Analysis, by Type of Packaging, 2020 and 2031

    Figure 76: Middle East & Africa Lyophilized Injectable Market Attractiveness Analysis, by Type of Packaging, 2021–2031

    Figure 77: Middle East & Africa Lyophilized Injectable Market Value Share Analysis, by Type of Delivery, 2020 and 2031

    Figure 78: Middle East & Africa Lyophilized Injectable Market Attractiveness Analysis, by Type of Delivery, 2021–2031

    Figure 79: Middle East & Africa Lyophilized Injectable Market Value Share Analysis, by Indication, 2020 and 2031

    Figure 80: Middle East & Africa Lyophilized Injectable Market Attractiveness Analysis, by Indication, 2021–2031

    Figure 81: Middle East & Africa Lyophilized Injectable Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 82: Middle East & Africa Lyophilized Injectable Market Attractiveness Analysis, by End-user, 2021–2031

Copyright © Transparency Market Research, Inc. All Rights reserved